PRODUCT

TB-500 (5 mg) + BPC-157 (5 mg) Stack

No short description available.

Quickstart Highlights

TB-500 (Thymosin β4) is a 43-amino-acid peptide that promotes tissue repair and regeneration through enhanced angiogenesis and cellular migration[1][2]. BPC-157 (Body Protection Compound-157) is a 15-amino-acid gastric peptide studied for accelerating musculoskeletal healing by upregulating growth factor signaling[3][4]. Stacking these peptides is a common research approach for synergistic tissue repair support.

TB-500 Reconstitution: Add 2.0 mL bacteriostatic water → 2.5 mg/mL concentration.
BPC-157 Reconstitution: Add 2.0 mL bacteriostatic water → 2.5 mg/mL concentration.
TB-500 Dosing: 1,250 mcg (50 units) twice weekly (Weeks 1–4), then once weekly (Weeks 5–12).
BPC-157 Dosing: 250–500 mcg (10–20 units) daily, titrated over 12 weeks.
Easy measuring: At 2.5 mg/mL, 1 unit = 0.01 mL = 25 mcg on a U-100 insulin syringe.
Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, refrigerate and use within ~30 days.

Reconstitution

Draw 2.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Support tissue repair, reduce inflammation, and accelerate recovery from musculoskeletal injuries[1][3].
Schedule:TB-500 twice weekly (loading) then once weekly (maintenance); BPC-157 daily throughout.
Dose Range:TB-500: 1,250 mcg per injection; BPC-157: 250–500 mcg daily.
Reconstitution:2.0 mL per 5 mg vial for both peptides (~2.5 mg/mL).
Storage:Refrigerate lyophilized and reconstituted solutions; use within ~30 days after reconstitution.

Dosage Protocols

BPC-157 Start:250 mcg daily for 2 weeks, then increase to 500 mcg daily.
Timing:Inject at consistent times; BPC-157 preferably near injury site.

Storage Instructions

Lyophilized:Store at 2–8 °C (35.6–46.4 °F); for long-term storage, −20 °C (−4 °F) is acceptable[9].
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~30 days; avoid freeze–thaw cycles.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) for TB-500; inject BPC-157 near the target tissue when possible[6].
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose, injection site, and any observations to maintain consistency.
Both peptides may be administered on the same day but at different injection sites.

How It Works

TB-500 mimics endogenous thymosin β4, modulating inflammation and activating repair pathways including PI3K/Akt and Notch signaling to enhance angiogenesis and cell migration[1][2]. It promotes actin sequestration and is studied for accelerating wound healing, reducing fibrosis, and improving function after ischemic or traumatic injuries. BPC-157 upregulates angiogenic pathways (including VEGF) and counteracts inflammatory cytokines[3]. Preclinical research demonstrates improved healing of muscle, tendon, ligament, and bone with no observed toxicity[4][5]. The combination targets complementary mechanisms: TB-500 for systemic tissue repair signaling and BPC-157 for localized healing support.

Lifestyle Factors

Prioritize adequate protein intake to support tissue repair and regeneration.
Incorporate appropriate physical therapy or mobility work as tolerated during recovery.
Prioritize sleep and stress management to optimize healing responses.
Stay hydrated and maintain balanced nutrition to support anabolic processes.

Injection Technique

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[7].
Do not aspirate for subcutaneous injections; inject slowly and steadily[7].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[8].
For BPC-157, injecting near the injury site may enhance local effects[4].

Benefits and Side Effects

Benefits

TB-500: Preclinical studies show accelerated wound closure, reduced fibrosis, and improved function after ischemic or traumatic injuries[1][2].
BPC-157: Preclinical models demonstrate accelerated recovery of tendon, ligament, muscle, and bone injuries with no observed toxicity[3][4]. One clinical series found pain relief in 7 of 12 patients after a single intraarticular knee injection[4].
Stack Rationale: The combination may offer complementary mechanisms—systemic repair signaling (TB-500) plus localized tissue healing (BPC-157).

TB-500 (5 mg) + BPC-157 (5 mg) Stack

Resources

Categories

Company